Search This Blog

Monday, November 11, 2019

Foamix Pharmaceuticals EPS beats by $0.05

Foamix Pharmaceuticals (NASDAQ:FOMX): Q3 GAAP EPS of -$0.41 beats by $0.05.
Cash and cash equivalents of $40.53M
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)